𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cytotoxic T lymphocyte activity to hepatitis B virus DNA-transfected HepG2 cells in patients with chronic hepatitis B

✍ Scribed by Ito, Yuji ;Kakumu, Shinichi ;Yoshioka, Kentaro ;Wakita, Takaji ;Ishikawa, Tetsuya ;Koike, Katsuro

Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
681 KB
Volume
28
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Changes in hepatitis B virus DNA-polymer
Changes in hepatitis B virus DNA-polymerase activity in patients with chronic infection
✍ Dr. A. Alberti; P. Pontisso; G. Realdi 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB 👁 1 views

## Abstract Levels of serum hepatitis B virus DNA‐polymerase (HBV‐DNAP) were studied longitudinally over variable periods of time in 16 HBV chronic carriers using a modified assay procedure developed to increase reproducibility. Ten patients were tested on a short‐term basis at 3‐ to 6‐hr intervals

Relationship Between Expression of Hepat
Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection
✍ Nikolai V. Naumov; Mario Mondelli; Graeme J. M. Alexander; Richard S. Tedder; Ad 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 721 KB

Previous studies demonstrated that peripheral blood lymphocytes are cytotoxic to autologous hepatocytes in patients with chronic hepatitis B virus infection. We examined whether cytotoxicity is specifically directed against hepatocytes expressing HBsAg or HBcAg. Viral antigens were detected by immun

Efficacy of lamivudine in patients with
Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB
✍ Nicolaos C. Tassopoulos; Riccardo Volpes; Giuseppe Pastore; Jenny Heathcote; Mar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

This placebo controlled, double-blind study evaluated the efficacy and safety of lamivudine in patients with hepatitis B e antigen (HBeAg)-negative/hepatitis B virus (HBV) DNA-positive chronic hepatitis B. Patients were randomized to receive 100 mg lamivudine orally once daily for 52 weeks (n ‫؍‬ 60

Phytohemagglutinin and concanavalin A ac
Phytohemagglutinin and concanavalin A activate hepatitis B virus in peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection
✍ Pascal Bouffard; Jean-Pierre Lamelin; Fabien Zoulim; Daniel Lepot; Christian Tre 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 798 KB

## Abstract Peripheral blood mononuclear cells (PBMC) from 25 patients with chronic hepatitis B were tested for the presence of free monomeric hepatitis B virus (HBV) DNA migrating as a single 3.2 Kb band by Southern blot analysis. The PBMC were cultured for 7 days in the presence of phytohemagglut

Regulatory T cells contribute to the imp
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
✍ Jeroen N. Stoop; Renate G. van der Molen; Carla C. Baan; Luc J. W. van der Laan; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

Chronic hepatitis B virus (HBV) infection is characterized by a weak immune response to HBV. Regulatory T cells (T(reg)) can suppress the function of effector T cells and may thus be key players in this impaired immune response. Changes in the functionality or number of T(reg) could explain the decr